Concord Biotech Limited

Equities

Market Closed - NSE India S.E. Other stock markets 04:35:07 05/06/2026 pm IST			5-day change	1st Jan Change
1,209.90 ^INR	-2.29%		+10.03%	-10.08%

02/06	Choice Equity Downgrades Concord Biotech to Reduce from Add; Price Target is INR1,045	MT
02/06	Jefferies Adjusts Concord Biotech's Price Target to INR1,020 From INR1,170, Keeps at Hold	MT

Published on 02/14/2025 at 04:00 pm IST - Modified on 11/14/2025 at 03:05 am IST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Ladies and gentlemen, good day, and welcome to the Q3 FY '25 earnings conference call of Concord Biotech Limited hosted by JM Financial.

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

02/06	Choice Equity Downgrades Concord Biotech to Reduce from Add; Price Target is INR1,045	MT
02/06	Jefferies Adjusts Concord Biotech's Price Target to INR1,020 From INR1,170, Keeps at Hold	MT
01/06	Concord Biotech Limited, Q4 2026 Earnings Call, Jun 01, 2026
29/05	Concord Biotech Limited Recommends Dividend for the Financial Year Ended March 31, 2026	CI
29/05	Concord Biotech Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
02/04	Concord Biotech Limited completed the acquisition of Celliimune Biotech Private Limited for 6.6 million.	CI
13/02	Jefferies Adjusts Concord Biotech's Price Target to INR1,170 From INR1,290, Keeps at Hold	MT
12/02	Concord Biotech Limited, Q3 2026 Earnings Call, Feb 12, 2026
11/02	Concord Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
11/02	Concord Biotech Dec-quarter consol net profit 644.8 million rupees	RE
11/02	Concord Biotech Limited Appoints Paritosh Trivedi as Company Secretary, Compliance Officer, Effective February 11, 2026	CI
24/12	Concord Biotech Limited Announces Resignation of Hina Patel as Company Secretary and Compliance Officer, Effective January 21, 2026	CI
18/12	Concord Biotech Names CFO	MT
18/12	Concord Biotech appoints Raviraj Karia as CFO	RE
18/12	Concord Biotech Limited Appoints Raviraj Karia as Chief Financial Officer, Effective December 18, 2025	CI